JP Patent

JP2014074059A — ｃ−Ｍｅｔモジュレーターおよびその使用

Assigned to Exelixis Inc · Expires 2014-04-24 · 12y expired

What this patent protects

【課題】プロテインキナーゼ酵素活性を調節するための化合物の製造方法の提供。【解決手段】式ＸＸＩａの化合物を調製するプロセス。【選択図】なし

USPTO Abstract

【課題】プロテインキナーゼ酵素活性を調節するための化合物の製造方法の提供。【解決手段】式ＸＸＩａの化合物を調製するプロセス。【選択図】なし

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: JP2014074059A
Jurisdiction: JP
Classification: —
Expires: 2014-04-24
Drug substance claim: No
Drug product claim: No
Assignee: Exelixis Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.